Discover the TTcoin (TC) Listing on XT
September 23, 2024 07:33 ET
|
XT Exchange
SINGAPORE, Sept. 23, 2024 (GLOBE NEWSWIRE) -- We are thrilled to announce that TTcoin (TC) has been listed on XT Exchange. The TC/USDT trading pair has been available in the Innovation Zone (Layer 2...
Form 8.3 - AXA INVESTMENT MANAGERS: REA Group Ltd
September 23, 2024 07:32 ET
|
AXA Investment Managers SA
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
Digital Remittance Market Opportunities and Strategies to 2033: Competitive Landscape and Company Profiles for PayPal, Revolut, MoneyGram, Remitly and WorldRemit
September 23, 2024 07:32 ET
|
Research and Markets
Dublin, Sept. 23, 2024 (GLOBE NEWSWIRE) -- The "Digital Remittance Global Market Opportunities and Strategies to 2033" report has been added to ResearchAndMarkets.com's offering.This report...
Class 1 Nickel Provides Update on Dundonald South Nickel Sulphide Deposit and the Alexo-Dundonald Advanced Nickel Sulphide Project, Timmins, Canada
September 23, 2024 07:30 ET
|
Class 1 Nickel and Technologies Limited
TORONTO, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Class 1 Nickel and Technologies Ltd. (CSE: NICO | OTCQB: NICLF) ("Class 1 Nickel" or the "Company") is pleased to provide an update on its advanced nickel...
FTI Consulting Adds EY Global M&A Leader to Transactions Practice
September 23, 2024 07:30 ET
|
FTI Consulting, Inc.
WASHINGTON, Sept. 23, 2024 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Brian Salsberg as a Senior Managing Director and Global Head of M&A in the...
BioAtla and Context Therapeutics Announce Exclusive Worldwide License Agreement to Develop and Commercialize BA3362, a Nectin-4 x CD3 T Cell Engaging Antibody
September 23, 2024 07:30 ET
|
Context Therapeutics Inc.
Context to obtain exclusive development and commercialization rights to BA3362 BioAtla to receive $15.0 million in upfront and near-term milestones, and further potential clinical, regulatory and...
COSCIENS Biopharma Inc. Provides Updates on Merger Integration, Management Succession Plans and Ongoing Development Programs
September 23, 2024 07:30 ET
|
COSCIENS Biopharma Inc.
TORONTO, ONTARIO, Sept. 23, 2024 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “Company”), a specialty biopharmaceutical company developing and...
The Distinguished Gentleman’s Drive Celebrates Its Fourth Year on Sunday, September 29, 2024
September 23, 2024 07:30 ET
|
Movember Canada
TORONTO, Sept. 23, 2024 (GLOBE NEWSWIRE) -- The Distinguished Gentleman’s Drive (DGD) is a celebration of classic style. It’s an on-road fundraising event that unites classic cars – aged 40 years...
Heritage Holding Closes Inaugural Fund with Support from Institutional Capital
September 23, 2024 07:30 ET
|
Heritage Holding
Fundraising Target Met in Four Months with $220 Million in Committed Capital Strong Interest from Institutional, High-Net-Worth and Existing Investors BOSTON, Sept. 23, 2024 (GLOBE NEWSWIRE)...
CLM Announces $300,000 Private Placement Flow-Through Financing
September 23, 2024 07:30 ET
|
Consolidated Lithium Metals Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Consolidated Lithium Metals Inc. (TSXV: CLM | OTCQB: JORFF...